Allspring Global Investments
NVAX icon

Allspring Global Investments’s Novavax NVAX Stock Holding History

Allspring Global Investments’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252K Buy
+26,613
New +$238K ﹤0.01% 1611
2025
Q4 		– Sell
-27,957
Closed -$266K – 1744
2025
Q3 		$266K Sell
27,957
-36
-0.1% -$280 ﹤0.01% 1505
2025
Q2 		$185K Buy
+27,993
New +$185K ﹤0.01% 1551
2024
Q4 		– Sell
-1,810
Closed -$22.9K – 2196
2024
Q3 		$22.9K Hold
1,810
– – ﹤0.01% 1981
2024
Q2 		$22.9K Buy
+1,810
New +$18.2K ﹤0.01% 2097
2023
Q4 		– Sell
-12,075
Closed -$87.4K – 2570
2023
Q3 		$87.4K Buy
12,075
+9,528
+374% +$76.1K ﹤0.01% 2052
2023
Q2 		$18.9K Hold
2,547
– – ﹤0.01% 2467
2023
Q1 		$17.6K Hold
2,547
– – ﹤0.01% 2525
2022
Q4 		$26.2K Sell
2,547
-22,051
-90% -$389K ﹤0.01% 2532
2022
Q3 		$447K Buy
24,598
+16,336
+198% +$708K ﹤0.01% 1607
2022
Q2 		$424K Sell
8,262
-7,839
-49% -$406K ﹤0.01% 1619
2022
Q1 		$1.19M Buy
16,101
+6,871
+74% +$613K ﹤0.01% 1783
2021
Q4 		$1.32M Buy
+9,230
New +$1.59M ﹤0.01% 1767

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Allspring Global Investments's NVAX Position: Q2 2026 in Review

Allspring Global Investments opened a new position in Novavax (NVAX) in Q2 2026: 26,613 shares worth $252K. The stake represents ﹤0.01% of the portfolio and ranks #1611 among its holdings. This is a return to the name: Allspring Global Investments previously reported a position in NVAX as recently as Q3 2025.

Allspring Global Investments first reported a position in NVAX in Q4 2021 and has held it in 13 quarters since. The position peaked at $1.32M in Q4 2021. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Allspring Global Investments held 26,613 shares of Novavax worth $252K as of Q2 2026.
  • Novavax was a new Allspring Global Investments position in Q2 2026.
  • Novavax made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1611 holding.
  • Allspring Global Investments first reported a position in Novavax in Q4 2021 and has held it in 13 quarters since.
  • Allspring Global Investments's Novavax position peaked at $1.32M in Q4 2021.
  • 268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.